Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Bakkavor shares jump as £1.2bn deal with food rival Greencore agreed

(Sharecast News) - Convenience food maker Greencore said it had reached agreement in principle to take over rival Bakkavor in a deal worth £1.2bn after two previous approaches were rejected- sending shares in the Icelandic company surging. The deal would create a company supplying supermarkets with burgers, sushi, pizza, sandwiches and ready meals with a combined turnover of £4bn.

Greencore on Wednesday said the board of Bakkavor had indicated the key financial terms "represent a value that it would be minded unanimously to recommend" to its shareholders if a formal offer was made.

Bakkavor shareholders would be entitled to receive 85p in cash and 0.604 Greencore shares along with the Bakkavor 2024 final dividend of 4.8p a share. Greencore shareholders would own approximately 56% and Bakkavor investors 44% of the combined group.

The offer represents a 32.5% premium to the closing price on March 13 when the initial possible offer became public.

Greencore on Tuesday said full-year earnings would be better than expected due to robust sales and cost control measures. New customer wins helped maintain strong revenue growth in its second quarter to March 28.

"After a song and dance around valuation, it looks like Greencore has finally hit upon the magic number to gobble up Bakkavor. While still subject to a firm offer and shareholder vote, the tone of the latest update implies that Bakkavor is now on board to combine forces with the sandwich maker," said AJ Bell investment director Russ Mould.

"There is strategic merit in parking the two companies together. They are big names in the UK food market...Greencore wants a bigger slice of the pie and devouring Bakkavor would take the business to the next level."

"It would represent quite a turnaround for Greencore which was derailed by the pandemic. More people being called back to the office has been great news for its sandwich sales. Greencore has sustained positive momentum by doing more work for existing clients and winning new ones."

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.